FDA, companies add 3 heartburn meds to recall amid cancer concerns

The Denton recall affects unexpired lots of 150 mg and 300 mg ranitidine tablets, while the Appco action affects 150 mg and 300 mg batches of its ranitidine hydrochloride capsules, the network reported.

Meanwhile, Mylan Pharmaceuticals issued a voluntary recall of three lots of Nizatidine capsules, known more commonly as Axid, on the same contamination fears, KAIT reported.

According to the FDA, the Mylan products were distributed nationwide to wholesalers, mail order and retail pharmacies as well as a distributor between June 2017 and August 2018.

None of the companies involved in these most recent recalls have received any reports of adverse effects from the drugs, the FDA confirmed.